The Seattle-based diagnostics firm's MRD segment, which contributed 92 percent of revenue, grew 33 percent year over year.
Adaptive Biotechnologies MRD Testing Drives…
The Seattle-based diagnostics firm's MRD segment, which contributed 92 percent of revenue, grew 33 percent year over year.